Free shipping on orders over $500 throughout NSW and to all interstate Capitals.
Currency
Toggle Nav
Cognition and Cancer
Regular Price
$70.95
Special Price
$63.86
$58.05
This book is essential reading for health care professionals involved in the clinical care of cancer patients with neurocognitive problems.
Stock Status:
Out of stock
Availability:
Out of stock
SKU
9781107411814
This book is a unique resource on the influence cancer and cancer treatments have on cognition. The majority of cancer patients on active treatment experience cognitive impairments often referred to as ‘chemobrain’ or ‘chemofog’. In addition, patients with primary or metastatic tumors of the brain often experience direct neurologic symptoms. This book helps health care professionals working with cancer patients who experience cognitive changes and provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions.
| Author | Edited by Christina A. Meyers , James R. Perry |
|---|---|
| Table Of Content | Preface List of contributors Part I. Cognition and the Brain: Measurement, Tools, and Interpretation: 1. Introduction Christina A. Meyers and James R. Perry 2. Clinical neuropsychology Jill B. Rich and Angela K. Troyer 3. Brain imaging investigation of chemotherapy-induced neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A. Ahles 4. Role of neuropsychological assessment in cancer patients Elana Farace 5. Neuropsychological assessment of adults with cancer Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel 6. Neuropsychological assessment of children with cancer Louise Penkman Fennell and Robert W. Butler Part II. Effects of Cancer and Cancer Treatment on Cognition: 7. Biological bases of radiation injury to the brain Edward G. Shaw and Mike E. Robbins 8. Chemotherapy and biological response modifier-related cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl 9. Effect of hormones and hormonal treatment on cognition Christien Schilder, Sanne Schagen and Frits van Dam 10. Low grade gliomas Martin J. B. Taphoorn and Charles G. Niel 11. High grade gliomas Michael J. Glantz and James R. Perry 12. Brain metastases Deepak Khuntia, Beela S. Mathew, Christina A. Meyers, Sterling Johnson and Minesh P. Mehta 13. Primary Central Nervous System lymphoma Denise D. Correa 14. Childhood brain tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler 15. Neurofibromatosis Bartlett D. Moore, III and John M. Slopis 16. Hematological malignancies Melissa Friedman and Mercedes Fernandez 17. Paraneoplastic disorders Edward Dropcho 18. Symptomatic therapies and supportive care issues Alan Valentine and Eduardo Bruera 19. Animal models and cancer related symptoms Adrian Dunn Part III. Interventions and Implications for Clinical Trials: 20. Behavioral strategies and rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec 21. Support services Bebe Guill and Renee H. Raynor 22. Pharmacologic interventions for the treatment of radiation-induced brain injury Edward G. Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason, Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp 23. Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S. Wefel. |
| Format | Paperback |
| Publish Date | 13 Dec 2012 |
Write Your Own Review